# Marval Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/marval-biosciences

- Industry: Biotechnology
- Headquarters: Houston, US
- Website: www.marvalbiosciences.com
- Total disclosed funding: $5.6M
- Latest round: Series C (Jul 25, 2012)
- Investors on record: 2

## About

Founded in 2007 and based in Houston, Texas, Marval Biosciences operates as a life sciences company that develops biomedical imaging agents. It develops liposomal nanocarriers to deliver CT contrast agents that are used to diagnose acute chest pain and reduce toxicity to patients.

## Funding rounds

- Series C, Jul 25, 2012, $2.5M — Frontier Venture Capital, Mercury
- Series B, Jan 19, 2010, $2.5M — Frontier Venture Capital, Mercury
- Series A, Sep 7, 2007, $0.6M — Frontier Venture Capital, Mercury

## Investors

- Frontier Venture Capital (https://capitalatlas.ai/funds/frontier-venture-capital) — Series A, Series B, Series C
- Mercury (https://capitalatlas.ai/funds/mercury) — Series A, Series B, Series C